Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Molecular alterations in prostate cancer.

Reynolds MA.

Cancer Lett. 2008 Nov 18;271(1):13-24. doi: 10.1016/j.canlet.2008.04.047. Epub 2008 Jun 12. Review.

PMID:
18554779
[PubMed - indexed for MEDLINE]
2.

Molecular changes in prostatic cancer.

Bott SR, Arya M, Shergill IS, Williamson M.

Surg Oncol. 2005 Aug;14(2):91-104. Review.

PMID:
15993579
[PubMed - indexed for MEDLINE]
3.

Molecular biology of prostate cancer.

Schulz WA, Burchardt M, Cronauer MV.

Mol Hum Reprod. 2003 Aug;9(8):437-48. Review.

PMID:
12837920
[PubMed - indexed for MEDLINE]
Free Article
4.

Genomic approaches to outcome prediction in prostate cancer.

Febbo PG.

Cancer. 2009 Jul 1;115(13 Suppl):3046-57. doi: 10.1002/cncr.24350. Review.

PMID:
19544546
[PubMed - indexed for MEDLINE]
Free Article
5.

Epigenetic mechanisms in the biology of prostate cancer.

Schulz WA, Hoffmann MJ.

Semin Cancer Biol. 2009 Jun;19(3):172-80. doi: 10.1016/j.semcancer.2009.02.006. Epub 2009 Feb 20. Review.

PMID:
19429481
[PubMed - indexed for MEDLINE]
6.

A systems approach to model metastatic progression.

Taylor BS, Varambally S, Chinnaiyan AM.

Cancer Res. 2006 Jun 1;66(11):5537-9. Review.

PMID:
16740685
[PubMed - indexed for MEDLINE]
Free Article
7.

Genomic profiling of prostate cancers from African American men.

Castro P, Creighton CJ, Ozen M, Berel D, Mims MP, Ittmann M.

Neoplasia. 2009 Mar;11(3):305-12.

PMID:
19242612
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Application of genomic technologies to human prostate cancer.

Li S, Bhamre S, Lapointe J, Pollack JR, Brooks JD.

OMICS. 2006 Fall;10(3):261-75. Review.

PMID:
17069507
[PubMed - indexed for MEDLINE]
9.

Clusterin is epigenetically regulated in prostate cancer.

Rauhala HE, Porkka KP, Saramäki OR, Tammela TL, Visakorpi T.

Int J Cancer. 2008 Oct 1;123(7):1601-9. doi: 10.1002/ijc.23658.

PMID:
18649357
[PubMed - indexed for MEDLINE]
10.

Molecular biology in prostate cancer.

Arap MA.

Arch Esp Urol. 2010 Jan-Feb;63(1):1-9. Review.

PMID:
20157214
[PubMed - indexed for MEDLINE]
11.

Clinical applications of expression profiling and proteomics in prostate cancer.

Masters JR.

Anticancer Res. 2007 May-Jun;27(3A):1273-6. Review.

PMID:
17593619
[PubMed - indexed for MEDLINE]
Free Article
12.

Introduction: RNA and the treatment of human cancer.

Bruserud O.

Curr Pharm Biotechnol. 2007 Dec;8(6):318-9. Review.

PMID:
18289038
[PubMed - indexed for MEDLINE]
13.

Genetic and microenvironmental implications in prostate cancer progression and metastasis.

Alberti C.

Eur Rev Med Pharmacol Sci. 2008 May-Jun;12(3):167-75. Review.

PMID:
18700688
[PubMed - indexed for MEDLINE]
14.

Genomic predictors of prostate cancer therapy outcomes.

Lewinshtein DJ, Porter CR, Nelson PS.

Expert Rev Mol Diagn. 2010 Jul;10(5):619-36. doi: 10.1586/erm.10.53.

PMID:
20629511
[PubMed - indexed for MEDLINE]
15.

Differential expression of osteocalcin during the metastatic progression of prostate cancer.

Gardner TA, Lee SJ, Lee SD, Li X, Shirakawa T, Kwon DD, Park RY, Ahn KY, Jung C.

Oncol Rep. 2009 Apr;21(4):903-8.

PMID:
19287987
[PubMed - indexed for MEDLINE]
16.

Genetic and epigenetic regulations of prostate cancer by genistein.

Molinié B, Georgel P.

Drug News Perspect. 2009 Jun;22(5):247-54. doi: 10.1358/dnp.2009.22.5.1378633. Review.

PMID:
19609462
[PubMed - indexed for MEDLINE]
17.

Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer.

Tamura K, Furihata M, Chung SY, Uemura M, Yoshioka H, Iiyama T, Ashida S, Nasu Y, Fujioka T, Shuin T, Nakamura Y, Nakagawa H.

Cancer Sci. 2009 May;100(5):914-9. doi: 10.1111/j.1349-7006.2009.01117.x. Epub 2009 Feb 26.

PMID:
19298603
[PubMed - indexed for MEDLINE]
18.

Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.

Watson SK, Woolcock BW, Fee JN, Bainbridge TC, Webber D, Kinahan TJ, Lam WL, Vielkind JR.

Prostate. 2009 Jun 15;69(9):961-75. doi: 10.1002/pros.20949.

PMID:
19267368
[PubMed - indexed for MEDLINE]
19.

Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.

Kela I, Harmelin A, Waks T, Orr-Urtreger A, Domany E, Eshhar Z.

Prostate. 2009 Jul 1;69(10):1034-44. doi: 10.1002/pros.20950.

PMID:
19343735
[PubMed - indexed for MEDLINE]
20.

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.

Ishkanian AS, Mallof CA, Ho J, Meng A, Albert M, Syed A, van der Kwast T, Milosevic M, Yoshimoto M, Squire JA, Lam WL, Bristow RG.

Prostate. 2009 Jul 1;69(10):1091-100. doi: 10.1002/pros.20959.

PMID:
19350549
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk